Opus Genetics Inc.

NASDAQ: IRD · Real-Time Price · USD
1.16
0.05 (4.50%)
At close: Aug 20, 2025, 3:59 PM
1.15
-0.86%
After-hours: Aug 20, 2025, 04:34 PM EDT

Opus Genetics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
2.88M 4.37M 4.3M 3.87M 1.11M 1.71M 1.69M 11.94M 3.67M 1.75M 39.85M n/a n/a n/a n/a 489K 100K n/a
Cost of Revenue
n/a 13K 10K n/a n/a n/a 3K 1K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a 4.37M 4.29M 3.87M 1.11M 1.71M 1.69M 11.94M 3.67M 1.75M 39.85M n/a n/a n/a n/a 489K 100K n/a
Operating Income
-8.91M -9.93M -38.03M -8.01M -8.33M -7.71M -5.43M 6.39M -5.39M -6.13M 34.21M -4.54M -4.94M -6.51M -6.15M -4.23M -7.14M -5.19M
Interest Income
n/a n/a n/a 500K 563K 600K n/a n/a n/a 367K n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-7.42M -8.19M -35.13M -7.53M -7.76M -7.11M -4.8M 5.58M -4.96M -5.79M 34.26M -4.53M -4.93M -6.59M -6.31M -4.23M -7.14M -39.01M
Net Income
-7.42M -8.19M -35.13M -7.53M -7.76M -7.11M -4.79M 5.56M -4.96M -5.79M 33.94M -4.53M -4.93M -6.59M -6.31M -4.23M -7.14M -39.01M
Selling & General & Admin
5.77M 6.35M 7.3M 2.89M 3.35M 4.67M 3.28M 2.06M 4.34M 2.29M 2.05M 1.7M 1.78M 1.74M 1.41M 1.59M 3.41M 1.7M
Research & Development
6.02M 7.95M 7.03M 8.98M 6.09M 4.75M 3.84M 3.49M 4.72M 5.59M 3.59M 2.83M 3.16M 4.77M 4.74M 3.13M 3.83M 3.48M
Other Expenses
n/a n/a 28M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
11.79M 14.3M 42.33M 11.88M 9.44M 9.42M 7.12M 5.55M 9.06M 7.88M 5.64M 4.54M 4.94M 6.51M 6.15M 4.72M 7.24M 5.19M
Interest Expense
35K 1.37M n/a n/a n/a n/a n/a 1.33M n/a n/a n/a n/a 4K 5K 2K n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
11.79M 14.3M 42.33M 11.88M 9.44M 9.42M 7.12M 5.55M 9.06M 7.88M 5.64M 4.54M 4.94M 6.51M 6.15M 4.72M 7.24M 5.19M
Income Tax Expense
n/a n/a n/a n/a n/a n/a -2K 14K n/a n/a 315K n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
63.38M 33.88M 31.57M 26.15M 25.83M 24.52M 21.52M 21.45M 20.96M 20.94M 20.81M 20.5M 19.5M 18.89M 17.85M 16.93M 13.61M 10.92M
Shares Outstanding (Diluted)
63.38M 33.88M 31.57M 26.15M 25.83M 24.52M 22M 22.41M 20.96M 20.94M 21.48M 20.5M 19.5M 18.89M 17.85M 16.93M 13.61M 10.92M
EPS (Basic)
-0.12 -0.24 -1.11 -0.29 -0.3 -0.29 -0.22 0.26 -0.24 -0.28 1.63 -0.22 -0.25 -0.35 -0.35 -0.25 -0.52 -3.57
EPS (Diluted)
-0.12 -0.24 -1.11 -0.29 -0.3 -0.29 -0.22 0.25 -0.24 -0.28 1.58 -0.22 -0.25 -0.35 -0.35 -0.25 -0.52 -3.57
EBITDA
-8.91M -6.81M -35.13M -7.53M -8.33M -7.71M -4.79M 6.9M -5.39M -6.13M 34.26M -4.53M -4.92M -6.59M -6.31M -4.23M -7.13M -39.01M
EBIT
-7.46M -6.82M -35.13M -7.53M -8.33M -7.71M -4.8M 6.9M -5.39M -6.13M 34.26M -4.53M -4.92M -6.59M -6.31M -4.23M -7.14M -39.01M
Depreciation & Amortization
n/a 13K 10K n/a n/a n/a 3K 1K 1K 1K 1K 1K 1K 1K 1K 1K 1K 1K